HIV Prevention Interventions for Adolescents

  • Sybil HosekEmail author
  • Audrey Pettifor
The Science of Prevention (JD Stekler and JM Baeten, Section Editors)
Part of the following topical collections:
  1. Topical Collection on The Science of Prevention


Purpose of Review

The goal of this paper is to review recent data on biomedical, behavioral, and structural HIV prevention interventions for adolescents and young adults.

Recent Findings

While it is accepted that HIV prevention interventions must take an integrated approach to achieve maximum effectiveness, to date, there have been limited, rigorously evaluated combination prevention interventions for adolescents. There are currently a range of effective biomedical, behavioral, and structural approaches that can be integrated into prevention packages to address the prevention needs of adolescents, including oral PrEP, male circumcision, rapid HIV testing, numerous behavioral interventions, and structural interventions such as cash transfers and community mobilization to address gender-based violence.


There is still a need for rigorously evaluated, innovative combination prevention packages for adolescents. Prevention approaches must take into account the context of young people’s lives and address the multiple levels of influence on their lives including parents, partners, and communities.


HIV/AIDS Adolescents Young adults Prevention 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

All reported studies with human subjects performed by the authors have been previously published and complied with all applicable ethical standards.


  1. 1.
    WHO, Health for the World’s Adolescents: a second chance in the second decade, World Health Organization, Geneva, 2014.Google Scholar
  2. 2.
    Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc. 2015;19:408. Scholar
  3. 3.
    Children and AIDS. Statistical Update. UNICEF December 2017Google Scholar
  4. 4.
    Youth Risk Behavior Surveillance Survey. 2015.
  5. 5.
    Geier CF. Adolescent cognitive control and reward processing: implications for risk taking and substance use. Horm Behav. 2013;64(2):333–42.Google Scholar
  6. 6.
    Smith AR, Chein J, Steinberg L. Impact of socio-emotional context, brain development, and pubertal maturation on adolescent risk-taking. Horm Behav. 2013;64(2):323–32.Google Scholar
  7. 7.
    Romer D. Adolescent risk taking, impulsivity, and brain development: implications for prevention. Dev Psychobiol. 2010;52(3):263–76.Google Scholar
  8. 8.
    Hawkins K, Price N, Mussa F. Milking the cow: young women’s construction of identity and risk in age-disparate transactional sexual relationships in Maputo, Mozambique. Glob Public Health. 2009;4(2):169–82. Scholar
  9. 9.
    Hallett TB, Gregson S, Lewis JJ, Lopman BA, Garnett GP. Behaviour change in generalized HIV epidemics: impact of reducing cross-generational sex and delaying age at sexual debut. Sex Transm Infect. 2007;83(Suppl 1):i50–4.Google Scholar
  10. 10.
    Lane T, Osmand T, Marr A, Shade SB, Dunkle K, Sandfort T, et al. The Mpumalanga Men’s Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa. PLoS One. 2014;9(11):e111063.Google Scholar
  11. 11.
    Kubicek K, McNeeley M, Collins S. “Same-sex relationship in a straight world” individual and societal influences on power and control in young men’s relationships. J Interpersonal Violence 2014:0886260514532527Google Scholar
  12. 12.
    Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet. 2010;376(9734):41–8. Scholar
  13. 13.
    Campbell JC, Baty ML, Ghandour RM, Stockman JK, Francisco L, Wagman J. The intersection of intimate partner violence against women and HIV/AIDS: a review. Int J Inj Control Saf Promot. 2008;15(4):221–31. Scholar
  14. 14.
    Jeffries WL, Greene KM, Paz-Bailey G, McCree DH, Scales L, Dunville R, et al. Determinants of HIV incidence disparities among young and older men who have sex with men in the United States. AIDS Behav. 2018;9:1–5.Google Scholar
  15. 15.
    Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann N Y Acad Sci. 2008;1124:111–26.Google Scholar
  16. 16.
    Walensky RP. Combination HIV prevention: the value and interpretation of mathematical models. Current HIV/AIDS Reports. 2013;10(3):195–8.Google Scholar
  17. 17.
    Pettifor A, Nguyen NL, Celum C, Cowan FM, Go V, Hightow-Weidman L. Tailored combination prevention packages and PrEP for young key populations. J Int AIDS Soc. 2015;18(2S1).Google Scholar
  18. 18.
    Celum C, Baeten JM, Hughes JP, Barnabas R, Liu A, Van Rooyen H, et al. Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations. JAIDS (1999). 2013;63(0 2):S213.Google Scholar
  19. 19.
    DiClemente RJ, Jackson JM. Towards an integrated framework for accelerating the end of the global HIV epidemic among young people. Sex Educ. 2014;14(5):609–21.Google Scholar
  20. 20.
    Bekker LG, Johnson L, Wallace M, Hosek S. Building our youth for the future. J Int AIDS Soc. 2015;18(2S1).Google Scholar
  21. 21.
    Wong V, Murray KR, Phelps BR, Vermund SH, McCarraherb DR. Adolescents, young people, and the 90–90–90 goals: a call to improve HIV testing and linkage to treatment. AIDS. 2017;31(Suppl 3):S191–4. Published online 2017 Jul 1. Scholar
  22. 22.
    Brown K, Williams DB, Kinchen S, et al. Status of HIV epidemic control among adolescent girls and young women aged 15–24 years — seven African Countries, 2015–2017. MMWR Morb Mortal Wkly Rep. 2018;67:29–32. Scholar
  23. 23.
    Johnson CC, Kennedy C, Fonner V, Siegfried N, Figueroa C, Dalal S, et al. Examining the effects of HIV self-testing compared to standard HIV testing services: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21594. Scholar
  24. 24.
    Zanolini A, Chipungu J, Vinikoor MJ, Bosomprah S, Mafwenko M, Holmes CB, et al. HIV self-testing in Lusaka Province, Zambia: acceptability, comprehension of testing instructions, and individual preferences for self-test kit distribution in a population-based sample of adolescents and adults. AIDS Res Hum Retrovir. 2018;34(3):254–60. Scholar
  25. 25.
    Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.Google Scholar
  26. 26.
    Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.Google Scholar
  27. 27.
    Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.Google Scholar
  28. 28.
    McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.Google Scholar
  29. 29.
    Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.Google Scholar
  30. 30.
    Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.Google Scholar
  31. 31.
    Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, et al. Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatr. 2017;171(11):1063–71.Google Scholar
  32. 32.
    K. Gill, J. Dietrich, G. Gray, T. Pidwell, F. Kayamba, T. Bennie, L. Myer, L. Johnson, H. Spiegel, C. Slack, V. Elharrar, A. Strode, J. Rooney, L.-G. Bekker. Pluspills: an open label, safety and feasibility study of oral pre-exposure prophylaxis (PrEP) in 15-19 year old adolescents in two sites in South Africa. Paper presented at IAS 2017; Paris, France.Google Scholar
  33. 33.
    Centers for Disease Control and Prevention (2014). Clinical guidelines for the use of pre-exposure prophylaxis to prevent HIV.Google Scholar
  34. 34.
    WHO (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV.Google Scholar
  35. 35.
    Cite FDA approval of PrEP for adolescentsGoogle Scholar
  36. 36.
    Digolo L, Ochieng C, Ngunjiri A, Kiragu M, Kyongo J, Otioso L, Mukoma W. Uptake of and Retention on HIV Pre Exposure Prophylaxis among adolescent girls and young women in Kenya. 8th International Workshop on Women and HIV, Boston, March 2–32,018.Google Scholar
  37. 37.
    Morgan E, Ryan DT, Newcomb ME, Mustanski B. High rate of discontinuation may diminish PrEP coverage among young men who have sex with men. AIDS Behav. 2018;4:1–4.Google Scholar
  38. 38.
  39. 39.
  40. 40.
    Biello KB, Hosek S, Drucker MT, Belzer M, Mimiaga MJ, Marrow E, et al. Preferences for injectable PrEP among young US cisgender men and transgender women and men who have sex with men. Arch Sex Behav. 2017;19:1–7.Google Scholar
  41. 41.
    Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, et al. Young women’s ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS Behav. 2018;20:1–2.Google Scholar
  42. 42.
    Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010:1168–74.Google Scholar
  43. 43.
    Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016.Google Scholar
  44. 44.
    Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375(22):2133–43.Google Scholar
  45. 45.
    McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, et al. A Phase 1 randomised, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007). PLoS One. 2013;8(4):e60147.Google Scholar
  46. 46.
    Cranston RD, Lama JR, Richardson BA, Carballo-Diéguez A, Ayudhya RP, Liu K, et al. MTN-017: A rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel. Clin Infect Dis. 2016:ciw832.Google Scholar
  47. 47.
    Auvert B, Tajaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomised, controlled intervention of male circumcision for reduced HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;3(5):e226.Google Scholar
  48. 48.
    Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56.Google Scholar
  49. 49.
    Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66.Google Scholar
  50. 50.
    World Health Organization/Joint United Nations Programme on HIV/AIDS. Joint strategic action framework to accelerate the scale-up of voluntary medical male circumcision for HIV prevention in Eastern and Southern Africa, 2012–2016. Geneva, Switzerland: WHO/UNAIDS, 2011Google Scholar
  51. 51.
    World Health Organization. Progress Brief: Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa. Geneva, July 2017.Google Scholar
  52. 52.
    Njeuhmeli E, Opuni M, Schnure M, Tchuenche M, Stegman P, Gold E, et al. Scaling up voluntary medical male circumcision for human immunodeficiency virus prevention for adolescents and young adult men: a modeling analysis of implementation and impact in selected countries. Clin Infect Dis. 2018;66(suppl_3):S166–72.Google Scholar
  53. 53.
    Kaufman MR, Patel EU, Dam KH, Packman ZR, Van Lith LM, Hatzold K, et al. Counseling received by adolescents undergoing voluntary medical male circumcision: moving toward age-equitable comprehensive human immunodeficiency virus prevention measures. Clin Infect Dis. 2018;66(suppl_3):S213–20.Google Scholar
  54. 54.
    Hergenrather KC, Emmanuel D, Durant S, Rhodes SD. Enhancing HIV prevention among young men who have sex with men: a systematic review of HIV behavioral interventions for young gay and bisexual men. AIDS Educ Prev. 2016;28(3):252–71.Google Scholar
  55. 55.
    Mwale M, Muula AS. Systematic review: a review of adolescent behavior change interventions [BCI] and their effectiveness in HIV and AIDS prevention in sub-Saharan Africa. BMC Public Health. 2017;17(1):718.Google Scholar
  56. 56.
    Córdova D, Lua FM, Ovadje L, Hong E, Castillo B, Salas-Wright CP. Randomized controlled trials of technology-based HIV/STI and drug abuse preventive interventions for African American and Hispanic Youth: systematic review. JMIR Public Health Surveill. 2017;3(4).Google Scholar
  57. 57.
    Garofalo R, Kuhns LM, Reisner SL, Biello K, Mimiaga MJ. Efficacy of an empowerment-based, group-delivered HIV prevention intervention for young transgender women: the Project LifeSkills randomized clinical trial. JAMA Pediatr. 2018.Google Scholar
  58. 58.
    Hightow-Weidman L, LeGrand S, Simmons R, Egger K, Choi SK. and Muessig. HealthMpowerment: Effects of a mobile phone-optimized, internet-based intervention on condomless anal intercourse among young black men who have sex with men and transgender women. Presented at IAS 2017; Paris. France.Google Scholar
  59. 59.
    Bauermeister JA, Muessig KE, LeGrand S, Flores DD, Choi SK, Dong W, et al. HIV and sexuality stigma reduction through engagement in online forums: results from the HealthMPowerment intervention. AIDS Behav. 2018:1–1.Google Scholar
  60. 60.
    Bretz F, Koenig F, Brannath W, Glimm E, Posch M. Adaptive designs for confirmatory clinical trials. Stat Med. 2009;28(8):1181–217.Google Scholar
  61. 61.
    Fitts DA. Improved stopping rules for the design of efficient small-sample experiments in biomedical and biobehavioral research. Behav Res Methods. 2010;42(1):3–22.Google Scholar
  62. 62.
    Sullivan PS, Carballo-Diéguez A, Coates T, Goodreau SM, McGowan I, Sanders EJ, et al. Successes and challenges of HIV prevention in men who have sex with men. Lancet. 2012;380(9839):388–99.Google Scholar
  63. 63.
    Hosek S, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, et al. Project PrEPare (ATN082): the acceptability and feasibility of an HIV pre-exposure prophylaxis (PrEP) trial with young men who have sex with men (YMSM). J Acquir Immune Defic Syndr. 2013;62(4).Google Scholar
  64. 64.
    Hosek SG, Green KR, Siberry G, Lally M, Balthazar C, Serrano PA, et al. Integrating behavioral HIV interventions into biomedical prevention trials with youth: lessons from Chicago’s Project PrEPare. Journal of HIV/AIDS & Social Services. 2013;12(3–4):333–48.Google Scholar
  65. 65.
    Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Mulligan K, Zimet G, Lally M. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. JAIDS (1999). 201774(1):21–9.Google Scholar
  66. 66.
    Pettifor A, MacPhail C, Hughes JP, Selin A, Wang J, Gómez-Olivé FX, et al. The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial. Lancet Glob Health. 2016;4(12):e978–88.Google Scholar
  67. 67.
    Stoner MC, Pettifor A, Edwards JK, Aiello AE, Halpern CT, Julien A, et al. The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068. AIDS. 2017;31(15):2127–34.Google Scholar
  68. 68.
    Abdool Karim Q, Leask K, Kharsany A, et al. Impact of conditional cash incentives on HSV-2 and HIV prevention in rural South African high school students: results of CAPRISA 007 cluster randomized trial; International AIDS Conference; Vancouver, Canada. July 19–22, 2015; TUAC0101LB.Google Scholar
  69. 69.
    Baird SJ, Garfein RS, McIntosh CT, Özler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379(9823):1320–9.Google Scholar
  70. 70.
    Cluver L, Boyes M, Orkin M, Pantelic M, Molwena T, Sherr L. Child-focused state cash transfers and adolescent risk of HIV infection in South Africa: a propensity-score-matched case-control study. Lancet Glob Health. 2013;1(6):e362–70.Google Scholar
  71. 71.
    Handa S, Halpern CT, Pettifor A, Thirumurthy H. The government of Kenya’s cash transfer program reduces the risk of sexual debut among young people age 15-25. PLoS One. 2014;9(1):e85473.Google Scholar
  72. 72.
    Cluver LD, Orkin FM, Boyes ME, Sherr L. Cash plus care: social protection cumulatively mitigates HIV-risk behaviour among adolescents in South Africa. AIDS. 2014;28:S389–97.Google Scholar
  73. 73.
    Roelen, K, Devereux, S, Abdulai, A, Martorano, B, Palermo, T, and Ragno, LP (2017). How to make “cash plus” work: linking cash transfers to services and sectors, Innocenti Working Paper 2017–10, UNICEF Office of Research, Florence.Google Scholar
  74. 74.
    Stoebenau K, Heise L, Wamoyi J, Bobrova N. Revisiting the understanding of “transactional sex” in sub-Saharan Africa: a review and synthesis of the literature. Soc Sci Med. 2016;168:186–97.Google Scholar
  75. 75.
    Ranganathan M, MacPhail C, Pettifor A, Kahn K, Khoza N, Twine R, et al. Young women’s perceptions of transactional sex and sexual agency: a qualitative study in the context of rural South Africa. BMC Public Health. 2017;17(1):666.Google Scholar
  76. 76.
    Mojola SA. Material girls and material love: consuming femininity and the contradictions of post-girl power among Kenyan schoolgirls. Continuum. 2015;29(2):218–29.Google Scholar
  77. 77.
    Shamu S, Gevers A, Mahlangu BP, Shai PNJ, Chirwa ED, Jewkes RK. Prevalence and risk factors for intimate partner violence among grade 8 learners in urban South Africa: baseline analysis from the Skhokho supporting success cluster randomised controlled trial. Int Health. 2016;8(1):18–26. Google Scholar
  78. 78.
    Russell M, Cupp PK, Jwkes RK, Gevers A, Mathews C, LeFleur-Bellerose C, et al. Intimate Partner Violence among Adolescents in Cape Town, South. Africa. 2014;15(3):283–95. Google Scholar
  79. 79.
    Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, et al. Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: a prospective cohort study. JAIDS. 2016;73(3):313.Google Scholar
  80. 80.
    Jewkes R, Nduna M, Levin J, Jama N, Dunkle K, Puren A, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ. 2008;337:a506.Google Scholar
  81. 81.
    Pronyk PM, Hargreaves JR, Kim JC, Morison LA, Phetla G, Watts C, et al. Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial. Lancet. 2006;368(9551):1973–83.Google Scholar
  82. 82.
    Abramsky T, Devries K, Kiss L, Nakuti J, Kyegombe N, Starmann E, et al. Findings from the SASA! Study: a cluster randomized controlled trial to assess the impact of a community mobilization intervention to prevent violence against women and reduce HIV risk in Kampala, Uganda. BMC Med. 2014;12(1):122.Google Scholar
  83. 83.
    Abramsky T, Devries KM, Michau L, Nakuti J, Musuya T, Kiss L, et al. Ecological pathways to prevention: How does the SASA! community mobilisation model work to prevent physical intimate partner violence against women? BMC Public Health. 2016;16(1):339.Google Scholar
  84. 84.
    Wagman JA, Gray RH, Campbell JC, Thoma M, Ndyanabo A, Ssekasanvu J, et al. Effectiveness of an integrated intimate partner violence and HIV prevention intervention in Rakai, Uganda: analysis of an intervention in an existing cluster randomised cohort. Lancet Glob Health. 2015;3(1):e23–33.Google Scholar
  85. 85.
    Hume M, Lewis LL, Nelson RM. Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies. J Med Ethics. 2017.Google Scholar
  86. 86.
    Bekker LG, Slack C, Lee S, Shah S, Kapogiannis B. Ethical issues in adolescent HIV research in resource-limited countries. JAIDS. 2014;65:S24–8.Google Scholar
  87. 87.
    Shah SK, Allison SM, Kapogiannis BG, Black R, Dawson L, Erbelding E. Advancing independent adolescent consent for participation in HIV prevention research. J Med Ethics. 2018;7:431–3.Google Scholar
  88. 88.
    Austrian, Karen, Paul C. Hewett, Erica SolerHampejsek, Fiammetta Bozzani, Jere R. Behrman, and Jean Digitale. 2016. Adolescent girls empowerment programme: research and evaluation mid-term technical report. Lusaka: Zambia. Population Council.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of PsychiatryJohn Stroger Hospital of Cook CountyChicagoUSA
  2. 2.Department of Epidemiology, Gillings School of Public HealthUniversity of North Carolina, Chapel HillChapel HillUSA

Personalised recommendations